샘플 요청 목록

 카트 문의
시장보고서
상품코드
1781239

세계의 심부전 POC 및 LOC 기기 시장

Heart Failure POC and LOC Devices
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 387 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

심부전 POC 및 LOC 기기 세계 시장은 2030년까지 2억 1,480만 달러에 달할 전망

2024년에 9,920만 달러로 추정되는 심부전 POC 및 LOC 기기 세계 시장은 2024-2030년 분석 기간에 CAGR 13.7%로 성장하여 2030년에는 2억 1,480만 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 단백질체 검사 유형은 CAGR 14.3%를 기록하며 분석 기간 종료시에는 1억 3,360만 달러에 달할 것으로 예측됩니다. 대사체 검사 유형의 성장률은 분석 기간 동안 CAGR 12.4%로 추정됩니다.

미국 시장은 추정 2,700만 달러, 중국은 CAGR 18.4%로 성장 예측

미국의 심부전 POC 및 LOC 기기 시장은 2024년에 2,700만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2030년까지 4,600만 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 18.4%를 기록할 것으로 예상됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 10.0%와 12.3%로 예측됩니다. 유럽에서는 독일이 CAGR 10.9%로 성장할 것으로 예측됩니다.

세계 심부전 POC 및 LOC 기기 시장 - 주요 동향 및 촉진요인 정리

심부전 관리에서 POC 및 LOC 기기가 중요한 이유는 무엇인가?

심부전은 여전히 전 세계 이환율과 사망률의 주요 원인으로, 신속한 진단 및 모니터링 솔루션에 대한 요구가 증가하고 있습니다. 현장 진료(POC) 및 랩온칩(LOC) 기기는 실시간 분산형 검사를 제공하고 기존 실험실 진단에 대한 의존도를 낮춤으로써 심부전 관리의 핵심 기술로 부상하고 있습니다. 이 기기들은 B형 나트륨 이뇨 펩타이드(BNP)와 트로포닌과 같은 바이오마커를 조기에 감지할 수 있어 의사가 심장 기능과 질병 진행을 보다 효율적으로 평가할 수 있게 해줍니다. 응급 현장이나 진료소, 또는 자택에서 즉시 그 자리에서 검사할 수 있게 됨에 따라 대응 시간이 크게 개선되어 조기 개입과 환자 예후 개선으로 이어졌습니다. 또한, 만성 심장질환, 생활습관 관련 위험요인의 증가, 고령화로 인해 접근성, 휴대성, 비용 효율성이 높은 심장 모니터링 도구에 대한 수요가 증가하고 있습니다. 헬스케어 산업이 예방 의료와 맞춤형 의료로 전환하는 가운데, POC 및 LOC 기기는 심부전 진단에 있어 혁신적인 역할을 수행하여 실시간 환자 모니터링을 보다 현실적이고 효과적으로 만들고 있습니다.

미세유체, AI, IoT는 어떻게 심부전 POC 및 LOC 기기를 강화할 것인가?

미세유체, 인공지능(AI), 사물인터넷(IoT)의 통합은 심부전 POC 및 LOC 기기의 기능에 혁명을 일으키고 있습니다. 미세유체 랩온칩 기술은 최소한의 혈액이나 타액으로 정확한 시료 분석이 가능하여 침습적 시술의 필요성을 줄여줍니다. AI 기반 진단 알고리즘은 검사 결과의 패턴을 분석하고 환자의 병력과 연관시켜 바이오마커 검출의 정확도를 높입니다. 심박수, 혈압, 체액 저장량을 지속적으로 모니터링할 수 있는 IoT 지원 웨어러블 바이오센서는 환자의 심혈관 건강 상태를 실시간으로 파악할 수 있습니다. 이러한 커넥티드 기기를 통해 의료진은 원격으로 환자를 추적하고, 이상 징후가 발견되면 알림을 받아 적극적인 개입을 할 수 있습니다. 클라우드 기반 데이터 통합을 통해 의료 시스템 간의 원활한 진단 정보 전달을 보장하고, 연계된 진료와 의사결정을 개선할 수 있습니다. 원격 모니터링과 원격의료에 대한 관심이 높아짐에 따라 이러한 기술 발전은 심부전 관리를 보다 예측적이고 개별화하여 병원 재입원을 줄이고 전체 생존율을 향상시키고 있습니다.

심부전증에 대한 POC 및 LOC 기기 도입에 어떤 장벽이 있는가?

심부전 POC 및 LOC 기기는 많은 장점이 있지만, 몇 가지 장벽이 보급을 방해하고 있습니다. 주요 과제 중 하나는 규제 당국의 승인이며, 심장 진단약은 정확성, 신뢰성, 안전성을 보장하기 위해 엄격한 검증이 필요합니다. FDA나 EMA와 같은 기관으로부터 규제 당국의 허가를 받는 과정은 시간이 오래 걸리며, 혁신적인 기기의 시장 진입을 지연시키고 있습니다. 첨단 미세유체 및 AI를 탑재한 진단 도구는 연구개발 및 제조에 많은 투자가 필요하기 때문에 도입에 드는 비용도 문제 중 하나입니다. 또한, 실시간 환자 모니터링을 위해서는 원활한 데이터 통합이 필수적이기 때문에 기존 전자건강기록(EHR) 및 헬스케어 시스템과의 상호운용성 확보가 여전히 과제로 남아있습니다. 또한, 기존 진단 방법이 여전히 시장을 독점하고 있기 때문에 POC 및 LOC 기기의 장점에 대한 임상의와 환자의 인식을 제고할 필요가 있습니다. 이러한 과제를 극복하기 위해서는 의료기기 제조업체, 규제 기관, 의료 서비스 제공자가 협력하여 보다 폭넓은 접근성과 채택을 보장해야 합니다.

심부전 POC 및 LOC 기기 시장의 성장 원동력은?

심부전 POC 및 LOC 기기 시장의 성장 원동력은 심혈관질환의 부담 증가, 미세유체공학 및 바이오센서 기술의 발전, 원격의료 서비스의 확대입니다. 의료비 지출 증가와 조기 발견 및 예방 의료로의 전환은 신속하고 분산된 진단 솔루션에 대한 수요를 촉진하고 있습니다. 재택 모니터링과 원격 환자 관리에 대한 관심이 높아지면서 휴대용 및 착용형 심부전 모니터링 기기의 채택이 가속화되고 있습니다. 심혈관 관련 입원 및 의료비 절감을 위한 정부의 노력도 시장 확대에 큰 역할을 하고 있습니다. 기술의 발전과 함께 심부전 POC 및 LOC 기기 시장은 성장하고, 전 세계 심혈관질환의 진단 및 관리 방식에 혁명을 가져올 것입니다.

부문

검사 유형(단백질체학 검사 유형, 대사체학 검사 유형, 유전체 검사 유형), 기술(미세유체 기술, 어레이 기반 시스템 기술, 기타 기술), 최종사용자(클리닉 최종사용자, 병원 최종사용자, 재택 최종사용자, 복지시설 최종사용자, 실험실 최종사용자)

조사 대상 기업 사례

  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • Alfa Scientific Designs, Inc.
  • American Screening Corporation
  • Baxter International Inc.
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories
  • CardioSignal
  • Danaher Corporation
  • Diagnoptics Technologies BV
  • F. Hoffmann-La Roche Ltd
  • Koninklijke Philips N.V.
  • Lepu Medical Technology
  • Medtronic plc
  • Murata Vios, Inc.
  • Nano-Ditech Corporation
  • Nova Biomedical
  • Siemens Healthineers
  • Ventric Health

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 LLM 및 업계 고유의 SLM을 조회하는 일반적인 규범을 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

ksm 25.08.07

Global Heart Failure POC and LOC Devices Market to Reach US$214.8 Million by 2030

The global market for Heart Failure POC and LOC Devices estimated at US$99.2 Million in the year 2024, is expected to reach US$214.8 Million by 2030, growing at a CAGR of 13.7% over the analysis period 2024-2030. Proteomic Testing Type, one of the segments analyzed in the report, is expected to record a 14.3% CAGR and reach US$133.6 Million by the end of the analysis period. Growth in the Metabolomic Testing Type segment is estimated at 12.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$27.0 Million While China is Forecast to Grow at 18.4% CAGR

The Heart Failure POC and LOC Devices market in the U.S. is estimated at US$27.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$46.0 Million by the year 2030 trailing a CAGR of 18.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 10.0% and 12.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.9% CAGR.

Global Heart Failure POC and LOC Devices Market - Key Trends & Drivers Summarized

Why Are Point-of-Care and Lab-on-a-Chip Devices Critical in Heart Failure Management?

Heart failure remains a leading cause of morbidity and mortality worldwide, creating a growing need for rapid diagnostic and monitoring solutions. Point-of-care (POC) and lab-on-a-chip (LOC) devices have emerged as crucial technologies in heart failure management, offering real-time, decentralized testing and reducing reliance on traditional laboratory diagnostics. These devices enable early detection of biomarkers such as B-type natriuretic peptide (BNP) and troponin, allowing physicians to assess cardiac function and disease progression more efficiently. The ability to conduct immediate, on-site tests in emergency settings, clinics, or even at home has significantly improved response times, leading to earlier interventions and better patient outcomes. Moreover, the increasing prevalence of chronic heart disease, lifestyle-related risk factors, and aging populations has heightened the demand for accessible, portable, and cost-effective cardiac monitoring tools. As the healthcare industry shifts toward preventive care and personalized medicine, POC and LOC devices are playing a transformative role in heart failure diagnostics, making real-time patient monitoring more feasible and effective.

How Are Microfluidics, AI, and IoT Enhancing POC and LOC Devices for Heart Failure?

The integration of microfluidics, artificial intelligence (AI), and the Internet of Things (IoT) is revolutionizing heart failure POC and LOC device capabilities. Microfluidic lab-on-a-chip technology enables precise sample analysis using minimal blood or saliva, reducing the need for invasive procedures. AI-driven diagnostic algorithms enhance the accuracy of biomarker detection by analyzing patterns in test results and correlating them with patient history. IoT-enabled wearable biosensors, capable of continuously monitoring heart rate, blood pressure, and fluid retention, are providing real-time insights into a patient’s cardiovascular health. These connected devices allow healthcare providers to remotely track patients and receive alerts for any abnormalities, enabling proactive interventions. Cloud-based data integration ensures seamless transmission of diagnostic information across healthcare systems, improving coordinated care and decision-making. With the growing emphasis on remote monitoring and telehealth, these technological advancements are making heart failure management more predictive and personalized, reducing hospital readmissions and improving overall survival rates.

What Barriers Exist in the Adoption of POC and LOC Devices for Heart Failure?

While heart failure POC and LOC devices offer numerous advantages, several barriers hinder their widespread adoption. One of the primary challenges is regulatory approval, as cardiac diagnostics require stringent validation to ensure accuracy, reliability, and safety. The process of obtaining regulatory clearance from agencies like the FDA and EMA can be time-consuming, delaying the market entry of innovative devices. Another challenge is the cost of implementation, as advanced microfluidic and AI-powered diagnostic tools require significant investment in research, development, and manufacturing. Additionally, ensuring interoperability with existing electronic health records (EHRs) and healthcare systems remains a hurdle, as seamless data integration is crucial for real-time patient monitoring. There is also a need for greater clinician and patient awareness regarding the benefits of POC and LOC devices, as traditional diagnostic methods continue to dominate the market. Overcoming these challenges will require collaborative efforts between medical device manufacturers, regulatory bodies, and healthcare providers to ensure broader accessibility and adoption.

What Is Driving the Growth of the Heart Failure POC and LOC Devices Market?

The growth in the heart failure POC and LOC devices market is driven by the increasing burden of cardiovascular diseases, advancements in microfluidics and biosensor technology, and the expansion of telehealth services. Rising healthcare expenditures and the shift toward early detection and preventive care have fueled demand for rapid and decentralized diagnostic solutions. The growing focus on home-based monitoring and remote patient management has accelerated the adoption of portable and wearable heart failure monitoring devices. Government initiatives aimed at reducing cardiovascular-related hospitalizations and healthcare costs are also playing a significant role in driving market expansion. As technology continues to advance, the heart failure POC and LOC devices market is set to grow, revolutionizing how cardiovascular diseases are diagnosed and managed worldwide.

SCOPE OF STUDY:

The report analyzes the Heart Failure POC and LOC Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Test Type (Proteomic Testing Type, Metabolomic Testing Type, Genomic Testing Type); Technology (Microfluidics Technology, Array-based Systems Technology, Other Technologies); End-Use (Clinics End-Use, Hospitals End-Use, Home End-Use, Assisted Living Healthcare Facilities End-Use, Laboratory End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 48 Featured) -

  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • Alfa Scientific Designs, Inc.
  • American Screening Corporation
  • Baxter International Inc.
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories
  • CardioSignal
  • Danaher Corporation
  • Diagnoptics Technologies BV
  • F. Hoffmann-La Roche Ltd
  • Koninklijke Philips N.V.
  • Lepu Medical Technology
  • Medtronic plc
  • Murata Vios, Inc.
  • Nano-Ditech Corporation
  • Nova Biomedical
  • Siemens Healthineers
  • Ventric Health

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Heart Failure POC and LOC Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Burden of Heart Failure Throws the Spotlight on Decentralized Diagnostic Technologies
    • Rapid Advancements in Microfluidics Drive Adoption of Lab-on-Chip Platforms for Cardiac Biomarker Detection
    • Growing Preference for Portable and Miniaturized Devices Expands Addressable Market Opportunity
    • Demand for Real-Time Monitoring in Emergency Settings Spurs Growth in POC Cardiac Testing Devices
    • Integration of Biosensors and Nanotechnology Strengthens Business Case for Next-Gen LOC Platforms
    • Shorter Turnaround Time in POC Testing Accelerates Demand in Critical Care and Home Settings
    • Increased Utilization of NT-proBNP and Troponin Assays Drives Adoption in Early Heart Failure Diagnosis
    • Healthcare Digitization and IoT Integration Propel Growth of Connected Heart Monitoring Solutions
    • Rising Incidence of Comorbid Conditions Such as Diabetes and Hypertension Expands Testing Demand
    • Clinical Shift Toward Preventive and Predictive Care Models Drives Adoption of Onsite Diagnostic Tools
    • Supportive Reimbursement Frameworks in Developed Markets Strengthen Market Viability
    • Cost-Effectiveness and Accessibility of POC Devices Generate Adoption in Rural and Remote Healthcare
    • Growing Adoption of Wearable Diagnostics Generates Momentum for Continuous Cardiac Function Monitoring
    • COVID-19 Pandemic Reinforces the Value Proposition of Decentralized Testing Infrastructure
    • Expansion of Home Healthcare Services Throws the Spotlight on Patient-Friendly Diagnostic Devices
    • Collaborations Between Diagnostic Companies and Academic Institutions Fuel Innovation in LOC Platforms
    • Stringent Regulatory Focus on Diagnostic Accuracy and Reliability Poses Challenges to Market Penetration
    • Rise in Public-Private Partnerships Accelerates Deployment of POC Solutions in Underserved Regions
    • Advances in AI-Powered Analytics Enhance Clinical Decision-Making from POC and LOC Data
    • Growing Need for Early Detection and Chronic Disease Management Propels Market Demand
    • Integration of LOC Devices with Smartphone Apps Expands Consumer Access and Usability
    • Shift Toward Value-Based Care Models Drives Investments in Rapid, Outcome-Oriented Diagnostic Tools
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Heart Failure POC and LOC Devices Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Heart Failure POC and LOC Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Heart Failure POC and LOC Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Proteomic Testing Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Proteomic Testing Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Proteomic Testing Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Metabolomic Testing Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Metabolomic Testing Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Metabolomic Testing Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Genomic Testing Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Genomic Testing Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Genomic Testing Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Assisted Living Healthcare Facilities End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Assisted Living Healthcare Facilities End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Assisted Living Healthcare Facilities End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Laboratory End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Laboratory End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Laboratory End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Home End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Home End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Home End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Microfluidics Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Microfluidics Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Microfluidics Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Array-based Systems Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Array-based Systems Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Array-based Systems Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Heart Failure POC and LOC Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Heart Failure POC and LOC Devices by Test Type - Percentage Breakdown of Value Sales for Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Heart Failure POC and LOC Devices by End-Use - Percentage Breakdown of Value Sales for Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Heart Failure POC and LOC Devices by Technology - Percentage Breakdown of Value Sales for Microfluidics Technology, Array-based Systems Technology and Other Technologies for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Heart Failure POC and LOC Devices by Test Type - Percentage Breakdown of Value Sales for Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Heart Failure POC and LOC Devices by End-Use - Percentage Breakdown of Value Sales for Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Heart Failure POC and LOC Devices by Technology - Percentage Breakdown of Value Sales for Microfluidics Technology, Array-based Systems Technology and Other Technologies for the Years 2015, 2025 & 2030
  • JAPAN
    • Heart Failure POC and LOC Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Heart Failure POC and LOC Devices by Test Type - Percentage Breakdown of Value Sales for Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Heart Failure POC and LOC Devices by End-Use - Percentage Breakdown of Value Sales for Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Heart Failure POC and LOC Devices by Technology - Percentage Breakdown of Value Sales for Microfluidics Technology, Array-based Systems Technology and Other Technologies for the Years 2015, 2025 & 2030
  • CHINA
    • Heart Failure POC and LOC Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Heart Failure POC and LOC Devices by Test Type - Percentage Breakdown of Value Sales for Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Heart Failure POC and LOC Devices by End-Use - Percentage Breakdown of Value Sales for Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Heart Failure POC and LOC Devices by Technology - Percentage Breakdown of Value Sales for Microfluidics Technology, Array-based Systems Technology and Other Technologies for the Years 2015, 2025 & 2030
  • EUROPE
    • Heart Failure POC and LOC Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Heart Failure POC and LOC Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Heart Failure POC and LOC Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Heart Failure POC and LOC Devices by Test Type - Percentage Breakdown of Value Sales for Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Heart Failure POC and LOC Devices by End-Use - Percentage Breakdown of Value Sales for Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use for the Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Heart Failure POC and LOC Devices by Technology - Percentage Breakdown of Value Sales for Microfluidics Technology, Array-based Systems Technology and Other Technologies for the Years 2015, 2025 & 2030
  • FRANCE
    • Heart Failure POC and LOC Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Heart Failure POC and LOC Devices by Test Type - Percentage Breakdown of Value Sales for Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Heart Failure POC and LOC Devices by End-Use - Percentage Breakdown of Value Sales for Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use for the Years 2015, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Heart Failure POC and LOC Devices by Technology - Percentage Breakdown of Value Sales for Microfluidics Technology, Array-based Systems Technology and Other Technologies for the Years 2015, 2025 & 2030
  • GERMANY
    • Heart Failure POC and LOC Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Heart Failure POC and LOC Devices by Test Type - Percentage Breakdown of Value Sales for Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Heart Failure POC and LOC Devices by End-Use - Percentage Breakdown of Value Sales for Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use for the Years 2015, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Heart Failure POC and LOC Devices by Technology - Percentage Breakdown of Value Sales for Microfluidics Technology, Array-based Systems Technology and Other Technologies for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Heart Failure POC and LOC Devices by Test Type - Percentage Breakdown of Value Sales for Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Heart Failure POC and LOC Devices by End-Use - Percentage Breakdown of Value Sales for Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use for the Years 2015, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Heart Failure POC and LOC Devices by Technology - Percentage Breakdown of Value Sales for Microfluidics Technology, Array-based Systems Technology and Other Technologies for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Heart Failure POC and LOC Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Heart Failure POC and LOC Devices by Test Type - Percentage Breakdown of Value Sales for Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Heart Failure POC and LOC Devices by End-Use - Percentage Breakdown of Value Sales for Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use for the Years 2015, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Heart Failure POC and LOC Devices by Technology - Percentage Breakdown of Value Sales for Microfluidics Technology, Array-based Systems Technology and Other Technologies for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Heart Failure POC and LOC Devices by Test Type - Percentage Breakdown of Value Sales for Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type for the Years 2015, 2025 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Heart Failure POC and LOC Devices by End-Use - Percentage Breakdown of Value Sales for Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use for the Years 2015, 2025 & 2030
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 130: Spain 15-Year Perspective for Heart Failure POC and LOC Devices by Technology - Percentage Breakdown of Value Sales for Microfluidics Technology, Array-based Systems Technology and Other Technologies for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Heart Failure POC and LOC Devices by Test Type - Percentage Breakdown of Value Sales for Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type for the Years 2015, 2025 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Heart Failure POC and LOC Devices by End-Use - Percentage Breakdown of Value Sales for Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use for the Years 2015, 2025 & 2030
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 139: Russia 15-Year Perspective for Heart Failure POC and LOC Devices by Technology - Percentage Breakdown of Value Sales for Microfluidics Technology, Array-based Systems Technology and Other Technologies for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Heart Failure POC and LOC Devices by Test Type - Percentage Breakdown of Value Sales for Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Heart Failure POC and LOC Devices by End-Use - Percentage Breakdown of Value Sales for Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 15-Year Perspective for Heart Failure POC and LOC Devices by Technology - Percentage Breakdown of Value Sales for Microfluidics Technology, Array-based Systems Technology and Other Technologies for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Heart Failure POC and LOC Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Heart Failure POC and LOC Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Heart Failure POC and LOC Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Heart Failure POC and LOC Devices by Test Type - Percentage Breakdown of Value Sales for Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type for the Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Heart Failure POC and LOC Devices by End-Use - Percentage Breakdown of Value Sales for Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use for the Years 2015, 2025 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 15-Year Perspective for Heart Failure POC and LOC Devices by Technology - Percentage Breakdown of Value Sales for Microfluidics Technology, Array-based Systems Technology and Other Technologies for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Heart Failure POC and LOC Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Heart Failure POC and LOC Devices by Test Type - Percentage Breakdown of Value Sales for Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type for the Years 2015, 2025 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Heart Failure POC and LOC Devices by End-Use - Percentage Breakdown of Value Sales for Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use for the Years 2015, 2025 & 2030
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 169: Australia 15-Year Perspective for Heart Failure POC and LOC Devices by Technology - Percentage Breakdown of Value Sales for Microfluidics Technology, Array-based Systems Technology and Other Technologies for the Years 2015, 2025 & 2030
  • INDIA
    • Heart Failure POC and LOC Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 170: India Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Heart Failure POC and LOC Devices by Test Type - Percentage Breakdown of Value Sales for Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type for the Years 2015, 2025 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Heart Failure POC and LOC Devices by End-Use - Percentage Breakdown of Value Sales for Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use for the Years 2015, 2025 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 178: India 15-Year Perspective for Heart Failure POC and LOC Devices by Technology - Percentage Breakdown of Value Sales for Microfluidics Technology, Array-based Systems Technology and Other Technologies for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Heart Failure POC and LOC Devices by Test Type - Percentage Breakdown of Value Sales for Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type for the Years 2015, 2025 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Heart Failure POC and LOC Devices by End-Use - Percentage Breakdown of Value Sales for Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use for the Years 2015, 2025 & 2030
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 187: South Korea 15-Year Perspective for Heart Failure POC and LOC Devices by Technology - Percentage Breakdown of Value Sales for Microfluidics Technology, Array-based Systems Technology and Other Technologies for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Heart Failure POC and LOC Devices by Test Type - Percentage Breakdown of Value Sales for Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type for the Years 2015, 2025 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Heart Failure POC and LOC Devices by End-Use - Percentage Breakdown of Value Sales for Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use for the Years 2015, 2025 & 2030
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Heart Failure POC and LOC Devices by Technology - Percentage Breakdown of Value Sales for Microfluidics Technology, Array-based Systems Technology and Other Technologies for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Heart Failure POC and LOC Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Heart Failure POC and LOC Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Heart Failure POC and LOC Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Heart Failure POC and LOC Devices by Test Type - Percentage Breakdown of Value Sales for Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type for the Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Heart Failure POC and LOC Devices by End-Use - Percentage Breakdown of Value Sales for Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use for the Years 2015, 2025 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 208: Latin America 15-Year Perspective for Heart Failure POC and LOC Devices by Technology - Percentage Breakdown of Value Sales for Microfluidics Technology, Array-based Systems Technology and Other Technologies for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Heart Failure POC and LOC Devices by Test Type - Percentage Breakdown of Value Sales for Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type for the Years 2015, 2025 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Heart Failure POC and LOC Devices by End-Use - Percentage Breakdown of Value Sales for Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use for the Years 2015, 2025 & 2030
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 217: Argentina 15-Year Perspective for Heart Failure POC and LOC Devices by Technology - Percentage Breakdown of Value Sales for Microfluidics Technology, Array-based Systems Technology and Other Technologies for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Heart Failure POC and LOC Devices by Test Type - Percentage Breakdown of Value Sales for Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type for the Years 2015, 2025 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Heart Failure POC and LOC Devices by End-Use - Percentage Breakdown of Value Sales for Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use for the Years 2015, 2025 & 2030
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 226: Brazil 15-Year Perspective for Heart Failure POC and LOC Devices by Technology - Percentage Breakdown of Value Sales for Microfluidics Technology, Array-based Systems Technology and Other Technologies for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Heart Failure POC and LOC Devices by Test Type - Percentage Breakdown of Value Sales for Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type for the Years 2015, 2025 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Heart Failure POC and LOC Devices by End-Use - Percentage Breakdown of Value Sales for Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use for the Years 2015, 2025 & 2030
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 235: Mexico 15-Year Perspective for Heart Failure POC and LOC Devices by Technology - Percentage Breakdown of Value Sales for Microfluidics Technology, Array-based Systems Technology and Other Technologies for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Heart Failure POC and LOC Devices by Test Type - Percentage Breakdown of Value Sales for Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Heart Failure POC and LOC Devices by End-Use - Percentage Breakdown of Value Sales for Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use for the Years 2015, 2025 & 2030
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Latin America 15-Year Perspective for Heart Failure POC and LOC Devices by Technology - Percentage Breakdown of Value Sales for Microfluidics Technology, Array-based Systems Technology and Other Technologies for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Heart Failure POC and LOC Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Heart Failure POC and LOC Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Heart Failure POC and LOC Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Heart Failure POC and LOC Devices by Test Type - Percentage Breakdown of Value Sales for Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type for the Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Heart Failure POC and LOC Devices by End-Use - Percentage Breakdown of Value Sales for Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use for the Years 2015, 2025 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 256: Middle East 15-Year Perspective for Heart Failure POC and LOC Devices by Technology - Percentage Breakdown of Value Sales for Microfluidics Technology, Array-based Systems Technology and Other Technologies for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Heart Failure POC and LOC Devices by Test Type - Percentage Breakdown of Value Sales for Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type for the Years 2015, 2025 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Heart Failure POC and LOC Devices by End-Use - Percentage Breakdown of Value Sales for Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use for the Years 2015, 2025 & 2030
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 265: Iran 15-Year Perspective for Heart Failure POC and LOC Devices by Technology - Percentage Breakdown of Value Sales for Microfluidics Technology, Array-based Systems Technology and Other Technologies for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Heart Failure POC and LOC Devices by Test Type - Percentage Breakdown of Value Sales for Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type for the Years 2015, 2025 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Heart Failure POC and LOC Devices by End-Use - Percentage Breakdown of Value Sales for Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use for the Years 2015, 2025 & 2030
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 274: Israel 15-Year Perspective for Heart Failure POC and LOC Devices by Technology - Percentage Breakdown of Value Sales for Microfluidics Technology, Array-based Systems Technology and Other Technologies for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Heart Failure POC and LOC Devices by Test Type - Percentage Breakdown of Value Sales for Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type for the Years 2015, 2025 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Heart Failure POC and LOC Devices by End-Use - Percentage Breakdown of Value Sales for Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use for the Years 2015, 2025 & 2030
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 283: Saudi Arabia 15-Year Perspective for Heart Failure POC and LOC Devices by Technology - Percentage Breakdown of Value Sales for Microfluidics Technology, Array-based Systems Technology and Other Technologies for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Heart Failure POC and LOC Devices by Test Type - Percentage Breakdown of Value Sales for Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type for the Years 2015, 2025 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Heart Failure POC and LOC Devices by End-Use - Percentage Breakdown of Value Sales for Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use for the Years 2015, 2025 & 2030
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 292: UAE 15-Year Perspective for Heart Failure POC and LOC Devices by Technology - Percentage Breakdown of Value Sales for Microfluidics Technology, Array-based Systems Technology and Other Technologies for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Heart Failure POC and LOC Devices by Test Type - Percentage Breakdown of Value Sales for Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type for the Years 2015, 2025 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Heart Failure POC and LOC Devices by End-Use - Percentage Breakdown of Value Sales for Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use for the Years 2015, 2025 & 2030
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Middle East 15-Year Perspective for Heart Failure POC and LOC Devices by Technology - Percentage Breakdown of Value Sales for Microfluidics Technology, Array-based Systems Technology and Other Technologies for the Years 2015, 2025 & 2030
  • AFRICA
    • Heart Failure POC and LOC Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Heart Failure POC and LOC Devices by Test Type - Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Heart Failure POC and LOC Devices by Test Type - Percentage Breakdown of Value Sales for Proteomic Testing Type, Metabolomic Testing Type and Genomic Testing Type for the Years 2015, 2025 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Heart Failure POC and LOC Devices by End-Use - Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Heart Failure POC and LOC Devices by End-Use - Percentage Breakdown of Value Sales for Assisted Living Healthcare Facilities End-Use, Laboratory End-Use, Clinics End-Use, Hospitals End-Use and Home End-Use for the Years 2015, 2025 & 2030
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Heart Failure POC and LOC Devices by Technology - Microfluidics Technology, Array-based Systems Technology and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 310: Africa 15-Year Perspective for Heart Failure POC and LOC Devices by Technology - Percentage Breakdown of Value Sales for Microfluidics Technology, Array-based Systems Technology and Other Technologies for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제